pre-ipo
Stage
1998
Founded
1
Investors
About
Cytokinetics is a specialty biopharmaceutical company focused on discovering, developing, and commercializing muscle biology-based therapies for diseases characterized by impaired muscle function, including cardiovascular and neuromuscular diseases.
Explore Cytokinetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.